
Evolent Health, Inc.
EVHNYSEHealthcareMedical - Healthcare Information Services
Previous close
$4.74
+$0.04 · +0.85%
EVH company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
36
Expensive
Momentum
64
Gaining
Sentiment
63
Bullish
Risk resilience
37
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteEvolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Seth Barrie Blackley
- Listed since
- Jun 5, 2015
- Employees
- 4,200
Market position
Day range
Current $4.74
52-week range
Current $4.74
- Open
- $4.61
- Previous close
- $4.70
- Volume
- 1.68M
- 0.56× average
- Average volume
- 2.99M
- Average daily volume
- Market cap
- 533.16M USD
- Beta
- 0.78
- Market reference 1
- 50-day average
- $4.7594
- -0.41% below average
- 200-day average
- $3.8815
- +22.12% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.29B USD
- P/E (TTM)
- -1.06×
- P/B (TTM)
- 1.39×
- P/S (TTM)
- 0.25×
- EV / EBITDA
- -3.58×
- Earnings yield
- -117.00%
- Free cash flow yield
- 1.04%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 12.92%
- Operating margin
- -1.37%
- Net margin
- -24.08%
- Return on equity
- -128.74%
- Return on assets
- -28.14%
- Return on invested capital
- -0.29%
Financial health
- Debt / equity
- 2.53×
- Current ratio
- 1.31×
- Altman Z-score
- -0.36
- Piotroski F-score
- 5 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.88B USD | 2.55B USD | 1.96B USD | 1.35B USD | 907.96M USD |
| Cost of goods sold | 1.59B USD | 2.19B USD | 1.5B USD | 1.04B USD | 657.55M USD |
| Gross profit | 284.03M USD | 367.35M USD | 460.47M USD | 316.58M USD | 250.41M USD |
| Research and development | — | — | — | 27M USD | — |
| Selling, general, and administrative | 288.47M USD | 263.05M USD | 358.11M USD | 269.27M USD | 219.5M USD |
| Operating expenses | 288.47M USD | 407.84M USD | 531.68M USD | 312.94M USD | 292.82M USD |
| Interest income | 4.19M USD | 5.54M USD | 5.26M USD | 1.37M USD | 407K USD |
| Interest expense | 57.47M USD | 24.72M USD | 54.21M USD | 15.57M USD | 25.43M USD |
| Depreciation and amortization | 115.85M USD | 123.17M USD | 123.42M USD | 90.25M USD | 60.04M USD |
| Operating income | −4.44M USD | −40.49M USD | −71.21M USD | 3.64M USD | −42.41M USD |
| Net income | −534.51M USD | −61.62M USD | −113.04M USD | −19.16M USD | −37.6M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 55%
- 6 beats, 5 misses, 0 met estimates
- Average EPS surprise
- +10.27%
- 11 comparable reports
- Latest EPS result
- 0.02
- Estimate -0.01 · Beat by 292.12%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
EVH news
EVH peers
ETFs holding EVH
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM13.82M0.02%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI10.46M0.00%2.3T USD0.03%$378.24+0.44%
Schwab Fundamental U.S. Small Company Index ETFFNDA4.33M0.05%9.26B USD0.25%$37.73+0.75%
Vanguard Extended Market ETFVXF4.02M0.00%93.7B USD0.05%$245.53+0.82%
Janus Henderson Small/Mid Cap Growth Alpha ETFJSMD3.83M0.34%1.08B USD0.30%$95.0557+0.68%
iShares Russell 2000 Value ETFIWN3.21M0.02%14.66B USD0.24%$224.81+0.45%
Schwab U.S. Small-Cap ETFSCHA2.49M0.01%23.1B USD0.03%$34.83+0.52%
Vanguard Russell 2000 ETFVTWO1.98M0.01%17.4B USD0.06%$121.25+0.74%
iShares Russell 2000 ETFIWM- Market value
- 13.82M
- Weight
- 0.02%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 10.46M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Schwab Fundamental U.S. Small Company Index ETFFNDA- Market value
- 4.33M
- Weight
- 0.05%
- AUM
- 9.26B USD
- Expense ratio
- 0.25%
- Price / 1D
- $37.73+0.75%
Vanguard Extended Market ETFVXF- Market value
- 4.02M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
Janus Henderson Small/Mid Cap Growth Alpha ETFJSMD- Market value
- 3.83M
- Weight
- 0.34%
- AUM
- 1.08B USD
- Expense ratio
- 0.30%
- Price / 1D
- $95.0557+0.68%
iShares Russell 2000 Value ETFIWN- Market value
- 3.21M
- Weight
- 0.02%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 2.49M
- Weight
- 0.01%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
Vanguard Russell 2000 ETFVTWO- Market value
- 1.98M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
Continue in GoAI
Research EVHresearch.disclaimer











